Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.1K Sell
333
-105
-24% -$22.5K ﹤0.01% 1193
2026
Q1
$96.9K Buy
438
+3
+0.7% +$734 ﹤0.01% 1046
2025
Q4
$110K Sell
435
-11
-2% -$2.76K ﹤0.01% 1011
2025
Q3
$110K Buy
446
+78
+21% +$18.7K ﹤0.01% 1028
2025
Q2
$88.4K Sell
368
-27
-7% -$6.29K ﹤0.01% 1097
2025
Q1
$89.5K Buy
395
+56
+17% +$12.3K ﹤0.01% 1043
2024
Q4
$69.7K Sell
339
-602
-64% -$132K ﹤0.01% 1095
2024
Q3
$207K Sell
941
-227
-19% -$53.1K ﹤0.01% 837
2024
Q2
$263K Buy
1,168
+1,112
+1,986% +$242K ﹤0.01% 603
2024
Q1
$12.6K Buy
56
+21
+60% +$4.74K ﹤0.01% 1382
2023
Q4
$8K Buy
35
+18
+106% +$3.81K ﹤0.01% 1681
2023
Q3
$4K Hold
17
﹤0.01% 1714
2023
Q2
$3K Sell
17
-163
-91% -$32.6K ﹤0.01% 1681
2023
Q1
$33K Buy
180
+136
+309% +$26.3K ﹤0.01% 1193
2022
Q4
$8K Sell
44
-6
-12% -$1.05K ﹤0.01% 1604
2022
Q3
$10K Buy
50
+4
+9% +$814 ﹤0.01% 1349
2022
Q2
$11K Buy
+46
New +$10.4K ﹤0.01% 1182

Other funds holding STE

Blue Trust Inc's STE Position: Q2 2026 in Review

Blue Trust Inc reduced its Steris (STE) stake by 24% in Q2 2026, selling an estimated $22.5K and leaving 333 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

Blue Trust Inc first reported a position in STE in Q2 2022 and has held it in 17 quarters since. The position peaked at $263K in Q2 2024. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Blue Trust Inc held 333 shares of Steris worth $70.1K as of Q2 2026.
  • Blue Trust Inc sold 105 Steris shares in Q2 2026, an estimated $22.5K.
  • Steris made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1193 holding.
  • Blue Trust Inc first reported a position in Steris in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Steris position peaked at $263K in Q2 2024.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.